News

All Releases
Tandem Diabetes Care to Announce First Quarter 2020 Financial Results on April 30, 2020
Apr 09, 2020
SAN DIEGO --(BUSINESS WIRE)--Apr. 9, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2020 results after the financial markets close on Thursday, April 30, 2020 .
Tandem Diabetes Care Announces Security Incident with Five Employee Email Accounts
Mar 16, 2020
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM) today announced that it will be notifying its customers of an information security incident involving five Tandem employee email accounts. On January 17, 2020 , the Company learned that an unauthorized user gained access to an
Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller
Mar 02, 2020
SAN DIEGO --(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of its Basal-IQ™ technology as an interoperable automated glycemic controller (iAGC).
Tandem Diabetes Care Announces Fourth Quarter and Full Year 2019 Financial Results and 2020 Financial Guidance
Feb 24, 2020
SAN DIEGO --(BUSINESS WIRE)--Feb. 24, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2019 and financial guidance for the year ending December 31, 2020 .
Data Presented at International Diabetes Conference Further Demonstrate Benefits of Tandem Diabetes Care Automated Insulin Delivery Technologies
Feb 20, 2020
MADRID --(BUSINESS WIRE)--Feb. 20, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced positive data presented today on its automated insulin delivery technologies, including data from a study of the t:slim X2™ insulin pump with
Tandem Diabetes Care Announces Upcoming Conference Presentations
Feb 14, 2020
SAN DIEGO --(BUSINESS WIRE)--Feb. 14, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will be attending the following upcoming investor conferences: SVB Leerink 9 th Annual Global Healthcare Conference on
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020
Jan 27, 2020
SAN DIEGO --(BUSINESS WIRE)--Jan. 27, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2019 results after the financial markets close on Monday, February 24, 2020 .
Tandem Diabetes Care Announces Commercial Launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States
Jan 15, 2020
SAN DIEGO --(BUSINESS WIRE)--Jan. 15, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its commercial launch of the t:slim X2™ insulin pump with Control-IQ™ technology, an advanced hybrid-closed loop feature designed to
Tandem Diabetes Care Appoints New Executive Vice President of Strategy and Corporate Development
Jan 09, 2020
SAN DIEGO --(BUSINESS WIRE)--Jan. 9, 2020-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Elizabeth Gasser as its new Executive Vice President, Strategy and Corporate Development.
Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology
Dec 13, 2019
Automated Insulin Dosing Software First to Receive New Classification by FDA SAN DIEGO --(BUSINESS WIRE)--Dec. 13, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration ( FDA ) clearance of the
Tandem Diabetes Care Announces Health Canada Approval of t:slim X2 Insulin Pump with Basal-IQ Predictive Low-Glucose Suspend Technology
Nov 20, 2019
SAN DIEGO --(BUSINESS WIRE)--Nov. 20, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada approval of the t:slim X2™ insulin pump with Basal-IQ™ technology. Basal-IQ technology, a predictive low-glucose suspend
Tandem Diabetes Care Announces Upcoming Conference Presentations
Nov 08, 2019
SAN DIEGO --(BUSINESS WIRE)--Nov. 8, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will be attending the following upcoming investor conferences: Credit Suisse 28 th Annual Healthcare Conference on
Tandem Diabetes Care Announces Third Quarter 2019 Financial Results and Updated 2019 Financial Guidance
Nov 04, 2019
SAN DIEGO --(BUSINESS WIRE)--Nov. 4, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2019 and updated its financial guidance for the year ending December 31, 2019 .
2019 Beyond Type Run Team to Race the TCS New York City Marathon Using Basal-IQ Technology from Tandem Diabetes Care
Nov 01, 2019
SAN DIEGO --(BUSINESS WIRE)--Nov. 1, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, is supporting the efforts of Beyond Type 1, a global diabetes advocacy organization, in fielding its largest marathon team in history, made up of 30
Tandem Diabetes Care Presents Positive Real-World Data from Pediatric Users of t:slim X2 Insulin Pump with Basal-IQ Technology at International Conference
Oct 30, 2019
SAN DIEGO --(BUSINESS WIRE)--Oct. 30, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced presentation of real-world data from pediatric users of the t:slim X2™ insulin pump with Basal-IQ® predictive low-glucose suspend
Tandem Diabetes Care Announces NEJM Publication of Landmark Study Demonstrating Increased Time-In-Range with the t:slim X2 Insulin Pump with Control-IQ Technology
Oct 16, 2019
SAN DIEGO --(BUSINESS WIRE)--Oct. 16, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by the New England Journal of Medicine (NEJM) of results from the landmark Protocol 3 study (DCLP3) of the National
Abbott and Tandem Diabetes Care Exploring New Integrated Solutions to Improve Diabetes Management
Oct 15, 2019
- Companies aim to integrate Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery products to expand choices for people with diabetes ABBOTT PARK, Ill. and SAN DIEGO , Oct. 15, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) and Tandem Diabetes Care (NASDAQ: TNDM) announced
Tandem Diabetes Care to Announce Third Quarter 2019 Financial Results on November 4, 2019
Oct 14, 2019
SAN DIEGO --(BUSINESS WIRE)--Oct. 14, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2019 results after the financial markets close on Monday, November 4, 2019 .
Tandem Diabetes Care Announces Publication of Real-world Basal-IQ Predictive Low Glucose Suspend Technology Data in Diabetes Technology and Therapeutics Journal
Sep 18, 2019
SAN DIEGO --(BUSINESS WIRE)--Sep. 18, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication of real-world data from more than 8,000 users of the t:slim X2™ insulin pump with Basal-IQ® predictive low-glucose suspend
Tandem Diabetes Care Announces Upcoming Conference Participation and Presentations
Aug 29, 2019
SAN DIEGO --(BUSINESS WIRE)--Aug. 29, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will be attending the following upcoming investor conferences: Baird Global Healthcare Conference on Wednesday,
Displaying 1 - 20 of 209